Paraneoplastic syndrome

Revision as of 11:31, 11 January 2009 by Zorkun (talk | contribs) (→‎Classification)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Paraneoplastic syndrome
DiseasesDB 2064
eMedicine med/1747 
MeSH D010257

WikiDoc Resources for Paraneoplastic syndrome

Articles

Most recent articles on Paraneoplastic syndrome

Most cited articles on Paraneoplastic syndrome

Review articles on Paraneoplastic syndrome

Articles on Paraneoplastic syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Paraneoplastic syndrome

Images of Paraneoplastic syndrome

Photos of Paraneoplastic syndrome

Podcasts & MP3s on Paraneoplastic syndrome

Videos on Paraneoplastic syndrome

Evidence Based Medicine

Cochrane Collaboration on Paraneoplastic syndrome

Bandolier on Paraneoplastic syndrome

TRIP on Paraneoplastic syndrome

Clinical Trials

Ongoing Trials on Paraneoplastic syndrome at Clinical Trials.gov

Trial results on Paraneoplastic syndrome

Clinical Trials on Paraneoplastic syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Paraneoplastic syndrome

NICE Guidance on Paraneoplastic syndrome

NHS PRODIGY Guidance

FDA on Paraneoplastic syndrome

CDC on Paraneoplastic syndrome

Books

Books on Paraneoplastic syndrome

News

Paraneoplastic syndrome in the news

Be alerted to news on Paraneoplastic syndrome

News trends on Paraneoplastic syndrome

Commentary

Blogs on Paraneoplastic syndrome

Definitions

Definitions of Paraneoplastic syndrome

Patient Resources / Community

Patient resources on Paraneoplastic syndrome

Discussion groups on Paraneoplastic syndrome

Patient Handouts on Paraneoplastic syndrome

Directions to Hospitals Treating Paraneoplastic syndrome

Risk calculators and risk factors for Paraneoplastic syndrome

Healthcare Provider Resources

Symptoms of Paraneoplastic syndrome

Causes & Risk Factors for Paraneoplastic syndrome

Diagnostic studies for Paraneoplastic syndrome

Treatment of Paraneoplastic syndrome

Continuing Medical Education (CME)

CME Programs on Paraneoplastic syndrome

International

Paraneoplastic syndrome en Espanol

Paraneoplastic syndrome en Francais

Business

Paraneoplastic syndrome in the Marketplace

Patents on Paraneoplastic syndrome

Experimental / Informatics

List of terms related to Paraneoplastic syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A paraneoplastic syndrome is a disease or symptom that is the consequence of the presence of cancer in the body, but is not due to the local presence of cancer cells. These phenomena are mediated by humoral factors (by hormones or cytokines) excreted by tumor cells or by an immune response against the tumor. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy.

Classification

Paraneoplastic syndromes can be divided into 4 main categories:

Neurological

A particularly devastating form of paraneoplastic syndromes is a group of disorders classified as paraneoplastic neurological disorders (PNDs).[6] These paraneoplastic disorders affect the brain and central nervous system and they are degenerative. Symptoms of paraneoplastic neurological disorders include ataxia (difficulty with walking and balance), dizziness, nystagmus (rapid uncontrolled eye movements), difficulty swallowing, loss of muscle tone, loss of fine motor coordination, slurred speech, memory loss, vision problems, sleep disturbances, dementia, seizures, sensory loss in the limbs.

The most common cancers associated with paraneoplastic neurological disorders are breast, ovarian and lung cancer, but many other cancers have been linked to PNDs as well.

Treatment options include:

  1. Therapies to eliminate the underlying cancer such as chemotherapy, radiation and surgery, and
  2. Therapies to reduce or slow neurological degeneration. Rapid diagnosis and treatment is critical for the patient to have the best chance of recovery. Since these disorders are relatively rare, few doctors have seen or treated PNDs. Therefore, it is important that PND patients consult with a specialist with experience in diagnosing and treating paraneoplastic neurological disorders.

Organizations

The International Paraneoplastic Association (IPA) is an organization dedicated to providing support and information to those affected by paraneoplastic neurological disorders.

References

  1. Cohen PR, Kurzrock R (1997). "Mucocutaneous paraneoplastic syndromes". Semin. Oncol. 24 (3): 334–59. PMID 9208889.
  2. Nervous+system+paraneoplastic+syndromes at the US National Library of Medicine Medical Subject Headings (MeSH)
  3. Dalmau J, Tüzün E, Wu HY; et al. (2007). "Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma". Ann. Neurol. 61 (1): 25–36. doi:10.1002/ana.21050. PMC 2430743. PMID 17262855. Unknown parameter |month= ignored (help)
  4. Staszewski H (1997). "Hematological paraneoplastic syndromes". Semin. Oncol. 24 (3): 329–33. PMID 9208888.
  5. Paraneoplastic+endocrine+syndromes at the US National Library of Medicine Medical Subject Headings (MeSH)
  6. Rees JH (2004). "Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage". J. Neurol. Neurosurg. Psychiatr. 75 Suppl 2: ii43–50. PMID 15146039.

External links

Template:Tumors Template:SIB

de:Paraneoplastisches Syndrom Template:WH Template:WikiDoc Sources